Welcome.
Are you a healthcare professional?

This website contains promotional information for Chiesi's respiratory products, and is intended solely for UK healthcare professionals. Please confirm below, or go back to the home page.

UK-RES-2000248 Feb 2020

You are now leaving Chiesi's website

By clicking this link, you will be taken to a website that is not owned or controlled by Chiesi. Chiesi is not responsible for the content provided on that site.

Continue
Go back

UK-RES-2000003 Jan 2020

INTENDED FOR UK HEALTHCARE PROFESSIONALS
Trimbow® Logo - beclometasone/formoterol/glycopyrronium (87/5/9 mcg) Extrafine formulation
Background

Prescribing Trimbow

trimbow_subheader-mobile

Each dose contains three established molecules for your adult patients with moderate to severe COPD not adequately treated with ICS/LABA or LABA/LAMA who need triple therapy1

Each metered dose contains:

  • 100mcg beclometasone
  • 6mcg formoterol
  • 10mcg glycopyrronium

 

Each delivered dose contains:

  • 87mcg beclometasone
  • 5mcg formoterol
  • 9mcg glycopyrronium

 

trimbow-inhaler-v2

Delivered dose is the dose leaving the mouthpiece, metered dose is the dose leaving the valve.

Trimbow contains beclometasone, formoterol and glycopyrronium in a solution formulation resulting in an aerosol with extrafine particles.1

Trimbow offers a familiar pMDI device, with twice-daily dosing[[1-3]]

Trimbow 87/5/9 is indicated for maintenance treatment in adult patients with moderate to severe COPD who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist or a combination of a long-acting β2-agonist and and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.1 of the Trimbow SPC).1

Two puffs in the morningTwo puffs in the evening

Trimbow is licensed for use with an AeroChamber Plus® spacer[[1]]

As a pMDI, Trimbow has the option to be used with an AeroChamber Plus® spacer.

  • Patients already familiar with a pMDI + spacer can use the same inhalation technique with Trimbow 1,4
  • The option of using Trimbow with an AeroChamber Plus® spacer can reduce oropharyngeal deposition and assist with hand-breath coordination 1,5

Trimbow device with an AeroChamber Plus attached

Dose counter[[1]]

Inclusion of a dose counter means patients can keep track of their remaining Trimbow doses at any time.1

Trimbow device with close up on the dose counter

AeroChamber Plus® is a registered trademark of Trudell Medical International. For additional information to share with your patients who have been prescribed Trimbow please visit our Trimbow patient and carer site.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.